BioMed Central | Articles which cite: Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.

home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
Torti C, Lapadula G, Casari S, Puoti M, Nelson M, Quiros-Roldan E, Bella D, Pastore G, Ladisa N, Minoli L, Sotgiu G, Mazzotta F, Lo Caputo S, Di Perri G, Filice G, Tinelli C, Carosi G, EPOKA-MASTER Study Group
BMC Infect Dis 2005, 5:58
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

BioMed Central articles that cite the above article:

Research article
Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania
Telatela SP, Matee MI, Munubhi EK
BMC Public Health 2007, 7:338 (22 November 2007)
[Full text] [PubMed Central] [PubMed] [Related articles]

Case report
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report
Lapadula G, Izzo I, Costarelli S, Cologni G, Bercich L, Casari S, Gambarotti M, Torti C
Journal of Medical Case Reports 2007, 1:19 (8 May 2007)
[Full text] [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]